Spots Global Cancer Trial Database for ovarian epithelial cancer
Every month we try and update this database with for ovarian epithelial cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CA-125 in Screening Patients at High Risk for Ovarian Cancer | NCT00080639 | Ovarian Cancer | physiologic tes... study of high r... | 30 Years - | University of Alabama at Birmingham | |
| Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer | NCT03220932 | Ovarian Epithel... | Cytoreductive s... Chemotherapy an... | 18 Years - 75 Years | Hospices Civils de Lyon | |
| Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer | NCT00460200 | Depression Fatigue Ovarian Cancer Psychosocial Ef... Sleep Disorders | polymorphism an... laboratory biom... physiologic tes... questionnaire a... conventional su... fatigue assessm... psychosocial as... | 18 Years - 55 Years | Jonsson Comprehensive Cancer Center | |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | NCT02096783 | Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer | informational i... counseling inte... questionnaire a... | 18 Years - | University of Wisconsin, Madison | |
| Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk | NCT00017134 | Ovarian Cancer | fenretinide conventional su... | 18 Years - | GOG Foundation | |
| Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity | NCT02518256 | Ovarian Epithel... | Lavage of the C... | 18 Years - 85 Years | Medical University of Vienna | |
| Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer | NCT02822157 | Ovarian Epithel... | Olaparib carboplatin + g... | 18 Years - 100 Years | Universitaire Ziekenhuizen KU Leuven | |
| Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary | NCT00626873 | Ovarian Cancer | Definity medical chart r... | 21 Years - | Icahn School of Medicine at Mount Sinai | |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | NCT00084370 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | celecoxib oophorectomy | 19 Years - | University of Alabama at Birmingham | |
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes. | NCT02062697 | Ovarian Epithel... | Lavage of the C... Liquid-PAP smea... | 18 Years - 80 Years | Medical University of Vienna | |
| AMT-151 in Patients With Selected Advanced Solid Tumours | NCT05498597 | Advanced Solid ... Advanced Cancer Advanced Carcin... Ovarian Cancer Ovarian Carcino... Ovarian Epithel... Ovarian Endomet... Endometrial Can... Endometrial Ade... Endometrial Ser... Endometrial End... Endometrial Cle... Lung Adenocarci... Triple Negative... Pancreatic Duct... Malignant Pleur... Ovarian Clear C... Ovarian Clear C... Ovarian Mucinou... | AMT-151 | 18 Years - | Multitude Therapeutics Inc. | |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | NCT00084370 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | celecoxib oophorectomy | 19 Years - | University of Alabama at Birmingham | |
| Screening Women at High Genetic Risk for Ovarian Cancer | NCT00033488 | Ovarian Cancer | cytology specim... annual screenin... comparison of s... | 35 Years - | National Cancer Institute (NCI) | |
| VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00436501 | Fallopian Tube ... Malignant Tumor... Recurrent Ovari... | docetaxel ziv-aflibercept laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | NCT00381888 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Thromboembolism Vaginal Cancer Vulvar Cancer | fondaparinux so... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00436501 | Fallopian Tube ... Malignant Tumor... Recurrent Ovari... | docetaxel ziv-aflibercept laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | NCT00610740 | Cervical Cancer Endometrial Can... Ovarian Cancer | topical gemcita... therapeutic con... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women | NCT00058032 | Ovarian Cancer | screening quest... annual screenin... | 50 Years - 74 Years | University College, London | |
| Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing | NCT04823871 | Ovarian Epithel... Carcinoma in Si... Ovarian Cancer | Speiser-cathete... | 18 Years - 80 Years | Medical University of Vienna | |
| Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | NCT01216813 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | informational i... assessment of t... psychosocial as... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
| CA-125 in Screening Patients at High Risk for Ovarian Cancer | NCT00080639 | Ovarian Cancer | physiologic tes... study of high r... | 30 Years - | University of Alabama at Birmingham | |
| Developing a Test for the Detection of Ovarian Cancer | NCT04794322 | Ovarian Neoplas... Ovarian Epithel... Fallopian Tube ... High Grade Ovar... Stage I Ovarian... Stage II Ovaria... Stage III Ovari... Stage IIIA Ovar... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IVA Ovari... Stage IVB Ovari... | Uterine lavage,... Blood sample Pap smear | 30 Years - | Massachusetts General Hospital | |
| Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma | NCT02039388 | Ovarian Epithel... Carcinoma in Si... Ovarian Cancer | Lavage of the C... | 18 Years - 80 Years | Medical University of Vienna | |
| Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France | NCT02981901 | Ovarian Epithel... | Patient with ov... | 18 Years - | Centre Leon Berard | |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy | NCT00084370 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | celecoxib oophorectomy | 19 Years - | University of Alabama at Birmingham | |
| Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer | NCT00699907 | Ovarian Cancer | flutamide | 18 Years - 83 Years | University of Arizona | |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | NCT00335491 | Bladder Cancer Breast Cancer Colorectal Canc... Esophageal Canc... Fatigue Lung Cancer Lymphoma Ovarian Cancer Prostate Cancer | exercise interv... complementary o... fatigue assessm... physical therap... | 60 Years - | University of Utah | |
| Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France | NCT02981901 | Ovarian Epithel... | Patient with ov... | 18 Years - | Centre Leon Berard | |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | NCT00377429 | Ovarian Cancer | catumaxomab | 18 Years - | Neovii Biotech | |
| Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer | NCT00039559 | Ovarian Cancer | Early detection | 30 Years - | Massachusetts General Hospital | |
| Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer | NCT05937620 | Ovarian Epithel... | 99mTC nanocollo... ICG injection | 18 Years - | Fundacion Clinic per a la Recerca Biomédica | |
| RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) | NCT02489903 | Small Cell Carc... Carcinoma, Non-... Neuroendocrine ... Ovarian Epithel... | RRx-001 Cisplatin Etoposide Carboplatin Irinotecan Vinorelbine Doxil Gemcitabine Taxane Paclitaxel Nab-Paclitaxel Pemetrexed | 18 Years - | EpicentRx, Inc. | |
| A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer | NCT04029909 | Ovarian Epithel... Fallopian Tube ... Primary Periton... | Gimatecan 0.6mg... 0.8mg/m2/d 0.4mg/m2/d | 18 Years - 65 Years | Lee's Pharmaceutical Limited | |
| Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer | NCT06404671 | Ovarian Epithel... | Delayed interva... Early interval ... | 18 Years - 75 Years | Alexandria University | |
| Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer | NCT00006099 | Ovarian Cancer | Monoclonal anti... | 18 Years - | Ludwig Institute for Cancer Research | |
| Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction | NCT00757952 | Ovarian Cancer | Fourier transfo... chromatography diagnostic labo... questionnaire a... | 21 Years - 120 Years | Pine Street Foundation | |
| Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries | NCT00098800 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | fenretinide | 30 Years - | University of Arizona | |
| CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | NCT00610740 | Cervical Cancer Endometrial Can... Ovarian Cancer | topical gemcita... therapeutic con... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | NCT01216813 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | informational i... assessment of t... psychosocial as... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
| Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk | NCT00017134 | Ovarian Cancer | fenretinide conventional su... | 18 Years - | GOG Foundation | |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | NCT01631552 | Gastric Adenoca... Esophageal Canc... Hepatocellular ... Non-small Cell ... Small Cell Lung... Ovarian Epithel... Carcinoma Breas... Hormone-refract... Head and Neck C... Renal Cell Canc... Urinary Bladder... Cervical Cancer Endometrial Can... Glioblastoma Mu... Triple Negative... Pancreatic Canc... | Sacituzumab Gov... | 18 Years - | Gilead Sciences | |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | NCT00335491 | Bladder Cancer Breast Cancer Colorectal Canc... Esophageal Canc... Fatigue Lung Cancer Lymphoma Ovarian Cancer Prostate Cancer | exercise interv... complementary o... fatigue assessm... physical therap... | 60 Years - | University of Utah | |
| Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes. | NCT02062697 | Ovarian Epithel... | Lavage of the C... Liquid-PAP smea... | 18 Years - 80 Years | Medical University of Vienna | |
| Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer | NCT03078400 | Ovarian Epithel... | SPL-108 | 18 Years - | Splash Pharmaceuticals, Inc. | |
| Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer | NCT00986206 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | Biomarker LPA a... | 18 Years - 95 Years | Women and Infants Hospital of Rhode Island | |
| CA-125 in Screening Patients at High Risk for Ovarian Cancer | NCT00080639 | Ovarian Cancer | physiologic tes... study of high r... | 30 Years - | University of Alabama at Birmingham | |
| Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer | NCT02742428 | Ascites Ovarian Epithel... Malnutrition | Systematic asci... Acute paracente... Interview. Quality of life... Nutritional sta... | 18 Years - | Gdynia Oncology Center | |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) | NCT05001282 | Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc... | ELU001 | 18 Years - | Elucida Oncology | |
| Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites | NCT00326885 | Malignant Ascit... | catumaxomab | 18 Years - | Neovii Biotech | |
| Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | NCT03349463 | Cervical Cancer Endometrial Can... Ovarian Epithel... | Fluciclovine F1... | 18 Years - | Loyola University | |
| Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France | NCT02981901 | Ovarian Epithel... | Patient with ov... | 18 Years - | Centre Leon Berard | |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | NCT02096783 | Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer | informational i... counseling inte... questionnaire a... | 18 Years - | University of Wisconsin, Madison | |
| Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer | NCT02822157 | Ovarian Epithel... | Olaparib carboplatin + g... | 18 Years - 100 Years | Universitaire Ziekenhuizen KU Leuven | |
| Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer | NCT00986206 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | Biomarker LPA a... | 18 Years - 95 Years | Women and Infants Hospital of Rhode Island | |
| Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer | NCT00039559 | Ovarian Cancer | Early detection | 30 Years - | Massachusetts General Hospital | |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | NCT00377429 | Ovarian Cancer | catumaxomab | 18 Years - | Neovii Biotech | |
| Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants | NCT00628654 | Ovarian Cancer | 21 Years - | University of California, Davis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
